| Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis M Galli, G Occhipinti, S Benenati, R Laborante, L Ortega-Paz, F Franchi, ... European Heart Journal-Cardiovascular Pharmacotherapy, pvae036, 2024 | | 2024 |
| Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction M Galli, G Niccoli, G De Maria, S Brugaletta, RA Montone, R Vergallo, ... Nature Reviews Cardiology 21 (5), 283-298, 2024 | 5 | 2024 |
| P2Y12 inhibition in patients requiring oral anticoagulation after percutaneous coronary intervention: the SWAP-AC–2 study L Ortega-Paz, W Bor, F Franchi, WWA van de Broek, F Rollini, S Giordano, ... JACC: Cardiovascular Interventions, 2024 | 1 | 2024 |
| TAILORING P2Y12 INHIBITING THERAPY IN PATIENTS REQUIRING ORAL ANTICOAGULATION AFTER UNDERGOING PERCUTANEOUS CORONARY … LO Paz, W Bor, F Franchi, W Van Den Broek, F Rollini, S GIORDANO, ... Journal of the American College of Cardiology 83 (13_Supplement), 847-847, 2024 | | 2024 |
| IMPACT OF CHRONIC KIDNEY DISEASE ON THE PHARMACODYNAMIC AND PHARMACOKINETIC PROFILES OF CLOPIDOGREL IN THE SETTING OF TYPE 2 DIABETES MELLITUS AND CORONARY ARTERY DISEASE LO Paz, F Franchi, F Rollini, M Galli, L Been, G Ghanem, A Shalhoub, ... Journal of the American College of Cardiology 83 (13_Supplement), 1161-1161, 2024 | | 2024 |
| Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in stable patients undergoing percutaneous coronary intervention: the TAPER-S randomized study D D'Amario, M Galli, A Restivo, F Canonico, R Vergallo, S Migliaro, ... European Heart Journal-Cardiovascular Pharmacotherapy 10 (3), 190-200, 2024 | 2 | 2024 |
| Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta‐analysis D D'Amario, R Laborante, E Bianchini, G Ciliberti, DA Paglianiti, M Galli, ... ESC heart failure, 2024 | 3 | 2024 |
| Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD L Ortega-Paz, F Franchi, F Rollini, M Galli, L Been, G Ghanem, ... JACC: Basic to Translational Science, 2024 | | 2024 |
| De-escalation versus shortening of dual antiplatelet therapy M Galli, F Costa, EP Navarese European Heart Journal-Cardiovascular Pharmacotherapy, pvae019, 2024 | | 2024 |
| Impact of ethnicity on antiplatelet treatment regimens for bleeding reduction in acute coronary syndromes: a systematic review and pre-specified subgroup meta-analysis M Galli, R Laborante, G Occhipinti, A Zito, L Spadafora, G Biondi-Zoccai, ... European Heart Journal-Cardiovascular Pharmacotherapy 10 (2), 158-169, 2024 | 4 | 2024 |
| “Ticking away the moments that make up a dull DAPT course”: Time matters M Galli, G Occhipinti International Journal of Cardiology 398, 2024 | | 2024 |
| Switching from dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor to dual pathway inhibition with aspirin plus vascular-dose rivaroxaban: the Switching Anti-Platelet … L Ortega-Paz, F Franchi, F Rollini, M Galli, L Been, G Ghanem, ... Thrombosis and Haemostasis 124 (03), 263-273, 2024 | 4 | 2024 |
| Role of the P2Y12 receptor on thrombus formation and evolution in therapeutic strategies M Galli, DJ Angiolillo Expert Opinion on Therapeutic Targets, 2024 | 2 | 2024 |
| Aspirin hypersensitivity and intolerance M Galli, G Occhipinti, DJ Angiolillo European Heart Journal-Cardiovascular Pharmacotherapy, pvae008, 2024 | | 2024 |
| Italian policy brief: La transizione digitale del Servizio pubblico in Italia M Scaglioni, A Nucci, M Galli Public Service Media in an Age of Platforms, 2024 | | 2024 |
| Bivalirudin in acute coronary syndromes M Galli, M Bernardi, L Ortega-Paz, R Nerla, D D’Amario, F Franchi, ... Expert Review of Cardiovascular Therapy 21 (12), 901-911, 2023 | 2 | 2023 |
| Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review G Carciotto, F Costa, V Garcia-Ruiz, M Galli, E Soraci, A Magliarditi, ... Journal of Clinical Medicine 12 (22), 7144, 2023 | | 2023 |
| Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials D D'Amario, R Laborante, E Bianchini, M Galli, G Ciliberti, M Mennuni, ... International Journal of Cardiology 391, 131219, 2023 | 6 | 2023 |
| Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular disease M Galli, G Cortellini, A Raiteri, M Lotrionte, F Fabio, A Romano European Heart Journal 44 (Supplement_2), ehad655. 2855, 2023 | | 2023 |
| Pharmacodynamic and pharmacokinetic profiles associated with switching from cangrelor to prasugrel in patients undergoing percutaneous coronary intervention: the SWAP-6 study F Franchi, F Rollini, L Ortega Paz, L Been, S Giordano, M Galli, ... European Heart Journal 44 (Supplement_2), ehad655. 2864, 2023 | | 2023 |
Filippo Creauniversità cattolica del sacro cuore di mino在 policlinicogemelli.it 的电子邮件经过验证
